Scientists discovered that a specific type of bacteria called Lacticaseibacillus paracasei UFTM 2.9 has strong potential to be used as a probiotic—a beneficial microorganism that supports digestive health. By analyzing the bacteria’s genetic code and testing it in the lab, researchers found that this strain can survive in your stomach and intestines, fight off harmful bacteria, and produce protective compounds. The bacteria showed no dangerous genes and successfully stopped the growth of 12 different types of harmful bacteria, including common culprits like E. coli and Staph infections. These findings suggest this bacteria could become a useful tool for improving gut health, though more human testing is needed before it reaches consumers.
The Quick Take
- What they studied: Whether a specific type of bacteria called Lacticaseibacillus paracasei UFTM 2.9 has the genetic traits and abilities needed to work as a probiotic supplement for gut health.
- Who participated: This was a laboratory study, not a human trial. Scientists analyzed the bacteria’s genetic code and tested it against 12 different harmful bacteria strains in controlled lab conditions.
- Key finding: The bacteria contains 170 genes linked to probiotic benefits, successfully stopped all 12 harmful bacteria tested, and has no dangerous genes that would make it unsafe to use.
- What it means for you: This bacteria shows real promise as a future probiotic supplement, but it’s still in early research stages. Don’t expect to buy it yet—scientists need to test it in humans first to confirm it’s safe and effective.
The Research Details
Researchers used a technique called probiogenomic analysis, which means they read the complete genetic instruction manual of the bacteria to understand what it can do. They sequenced the bacteria’s entire genome—all 3.2 million genetic letters—to identify which genes control helpful functions like surviving stomach acid, sticking to intestinal walls, and fighting bad bacteria.
They also grew the bacteria in the lab under different conditions to see how versatile it was. The team tested whether it could use five different types of food sources for energy, which shows how adaptable it might be in your digestive system. Finally, they put the bacteria directly against 12 different harmful bacteria strains to see if it could stop their growth.
This approach is valuable because it combines genetic analysis with practical lab testing, giving scientists confidence that the bacteria has both the genetic potential and real-world ability to work as a probiotic.
Understanding a bacteria’s genetic blueprint before testing it in humans is crucial for safety and effectiveness. By reading the genetic code first, scientists can confirm the bacteria won’t produce toxins or cause infections. This genetic screening saves time and makes human trials safer because researchers already know the bacteria lacks dangerous genes.
This study is solid foundational research published in a respected nutrition science journal. The researchers used standard scientific methods and found no red flags in the bacteria’s genetics. However, this is laboratory research only—the bacteria hasn’t been tested in human bodies yet. The sample size of 106 refers to the number of genes analyzed, not human participants. Real-world effectiveness in people remains to be proven.
What the Results Show
The bacteria’s genetic analysis revealed 170 genes associated with probiotic benefits. The largest group—106 genes—helps the bacteria survive harsh conditions like stomach acid and bile. Another 12 genes help it stick to intestinal walls, which is important because bacteria need to stay in your gut to help you. Ten genes are involved in making vitamins that your body needs.
Critically, the researchers found no virulence genes—these are genes that would make the bacteria dangerous or cause infections. This is a major safety indicator. The bacteria also lacks CRISPR elements, which are genetic tools that some bacteria use to attack other cells.
When tested against harmful bacteria in the lab, Lacticaseibacillus paracasei UFTM 2.9 successfully inhibited all 12 test strains, including dangerous ones like Listeria, Staph aureus, and E. coli. The bacteria produces compounds called bacteriocins—natural antibiotics that kill or stop harmful bacteria without harming human cells.
The bacteria showed metabolic versatility, meaning it can use multiple food sources for energy. This suggests it could adapt to different parts of your digestive system where different nutrients are available. The researchers also identified two phages (viruses that infect bacteria) in the strain, which is actually a positive sign—these phages help keep the bacteria population in check naturally.
This research builds on earlier work showing that this specific bacterial strain had probiotic properties in lab tests. The new study goes deeper by analyzing the genetic reasons why it works. The findings align with what scientists know about other successful probiotics—they typically have stress-resistance genes, adhesion genes, and the ability to produce protective compounds. This strain checks all those boxes.
This is laboratory research only—no human testing has been done yet. The bacteria was tested against harmful bacteria in controlled conditions that don’t perfectly match your actual digestive system. Real guts are much more complex, with hundreds of different bacteria species interacting. Additionally, the presence of two phages in the bacteria could potentially affect how stable it is as a supplement. Finally, the study doesn’t tell us what dose would be effective or whether the bacteria would survive the manufacturing and storage process needed for commercial supplements.
The Bottom Line
Based on this research alone, there are no recommendations for consumer use yet. This is early-stage research showing potential. If you’re interested in probiotics now, stick with established strains that have human trial data. Keep an eye out for future research on this strain—if it passes human safety and effectiveness trials, it could become a useful option. Confidence level: This is promising preliminary research, but not yet ready for real-world application.
Gastroenterologists and probiotic researchers should pay attention to this work. People with digestive issues or those interested in gut health should be aware this is in development. People currently taking probiotics don’t need to change anything based on this single study. Anyone with compromised immune systems should wait for human trial data before considering any new probiotic.
This is a multi-year process. If researchers move forward with human trials, it typically takes 2-5 years to complete safety and effectiveness studies. If successful, it could take another 1-2 years to develop a commercial product. Realistically, this bacteria won’t be available as a consumer product for at least 3-5 years, if it proves successful in human testing.
Want to Apply This Research?
- Once this or similar probiotics become available, users could track daily probiotic intake (strain name and dose) alongside digestive symptoms like bloating, regularity, and energy levels using a simple daily checklist in the app.
- When this bacteria becomes available as a supplement, users could set a daily reminder to take it at the same time each day, ideally with food. The app could track consistency of use and correlate it with digestive wellness metrics.
- Users could maintain a 12-week tracking log comparing baseline digestive health (before starting) to ongoing status, noting any changes in bloating, digestion speed, or overall comfort. The app could generate monthly reports showing trends and help users decide if the probiotic is working for their individual system.
This research describes laboratory findings only and has not been tested in humans. The bacteria strain discussed is not yet available as a consumer product. This information is for educational purposes and should not be used to diagnose, treat, or prevent any disease. Anyone considering probiotic supplements should consult with their healthcare provider, especially those with compromised immune systems, serious illnesses, or those taking medications. Always speak with a doctor before starting any new supplement regimen.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.